Format

Send to

Choose Destination
BMC Infect Dis. 2017 Jun 7;17(1):402. doi: 10.1186/s12879-017-2500-z.

Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia.

Author information

1
Department of Pediatrics, Seoul National University Children's Hospital, Seoul, South Korea.
2
Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
3
Department of Radiology, Seoul National University Hospital, Seoul, South Korea.
4
Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, South Korea.
5
Department of Pediatrics, Eulji Hospital, Seoul, South Korea.
6
Department of Pediatrics, Chungnam National University Hospital, Daejeon, South Korea.
7
Department of Pediatrics, Chonnam National University Hospital, Gwangju, South Korea.
8
Department of Pediatrics, Seoul National University Children's Hospital, Seoul, South Korea. eunchoi@snu.ac.kr.
9
Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea. eunchoi@snu.ac.kr.

Abstract

BACKGROUND:

With the emergence of macrolide resistance, concerns about the efficacy of macrolides for the treatment of Mycoplasma pneumoniae (MP) pneumonia in children have been raised. This study aimed to determine the effect of macrolide resistance on the outcome of children who were hospitalized with MP pneumonia.

METHODS:

Between 2010 and 2015, we performed culture of MP from nasopharyngeal samples obtained from children who were hospitalized with pneumonia at five hospitals in Korea. Macrolide resistance was determined by the analysis of 23S rRNA gene transition and the minimal inhibitory concentrations of four macrolides. Medical records were reviewed to analyze the clinical response to treatment with macrolides.

RESULTS:

MP was detected in 116 (4.8%) of the 2436 children with pneumonia. MP pneumonia was prevalent in 2011 and 2015. Of the 116 patients with MP pneumonia, 82 (70.7%) were macrolide-resistant. There were no differences in the age distribution, total duration of fever, and chest x-ray patterns between the macrolide-susceptible and macrolide-resistant groups. After macrolide initiation, mean days to defervescence were longer in the macrolide-resistant group than in macrolide-susceptible group (5.7 days vs. 4.1 days, P = 0.021). However, logistic regression analysis revealed that the presence of extrapulmonary signs (P = 0.039), homogeneous lobar consolidation (P = 0.004), or parapneumonic effusion (P < 0.001) were associated with fever duration of ≥7 days after the initiation of macrolides, regardless of macrolide resistance.

CONCLUSIONS:

This study demonstrated that fever duration in MP pneumonia was determined by the radiologic findings of chest x-ray, not by the presence of macrolide resistance. The results highlight the need for future studies to assess therapeutic benefit from macrolides in the treatment of children with MP pneumonia.

KEYWORDS:

Macrolides; Mycoplasma pneumoniae; Pneumonia; Radiologic findings; Resistance

PMID:
28592263
PMCID:
PMC5463359
DOI:
10.1186/s12879-017-2500-z
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center